| 000 | 01664 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514231853.0 | ||
| 264 | 0 | _c20050728 | |
| 008 | 200507s 0 0 eng d | ||
| 022 | _a0024-3205 | ||
| 024 | 7 |
_a10.1016/j.lfs.2005.02.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Shu-Jing | |
| 245 | 0 | 0 |
_aCinnamaldehyde-induced apoptosis in human PLC/PRF/5 cells through activation of the proapoptotic Bcl-2 family proteins and MAPK pathway. _h[electronic resource] |
| 260 |
_bLife sciences _cJul 2005 |
||
| 300 |
_a938-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcrolein _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAnnexin A5 _xmetabolism |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xmetabolism |
| 650 | 0 | 4 | _aCaspase 8 |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aG1 Phase _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xphysiology |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 3 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
| 700 | 1 | _aNg, Lean-Teik | |
| 700 | 1 | _aLin, Chun-Ching | |
| 773 | 0 |
_tLife sciences _gvol. 77 _gno. 8 _gp. 938-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lfs.2005.02.005 _zAvailable from publisher's website |
| 999 |
_c15622791 _d15622791 |
||